天然药物向瘤血管微环境,以抑制瘤
Yirui Lu1, Zhiliang Guo2, Hong Li1
1School of Basic Medicine Sciences, Shandong Second Medical University, Weifang, Shandong 261053, China.
Genes & diseases
|August 18, 2025
概括
瘤血管不规则,导致血液流动不良和缺氧. 通过天然药物调节这些血管和机械微环境,有望抑制瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
背景情况:
- 瘤血管系统异常活跃,通过血管性因素促进瘤的快速增殖.
- 瘤生长导致不规则,不成熟的血管,导致低输液,高间歇性压力和缺氧.
- 瘤微环境中的改变流体力学会影响循环瘤细胞的行为和功能.
研究的目的:
- 审查瘤血管生成,瘤微环境中的机械变化,以及细胞对流体剪切应激反应.
- 探索血管正常化作为针对瘤血管的治疗策略.
- 通过向瘤血管,突出自然药物在癌症治疗中的潜力.
主要方法:
- 审查关于瘤血管生成和机械微环境的现有文献.
- 对流体剪切应力对瘤细胞和血管系统的影响研究的分析.
- 检查天然药物在向瘤血管和增强抗癌疗法的作用.
主要成果:
- 异常的瘤血管和改变的流体机制创造了一个独特的瘤微环境.
- 机械条件显著影响瘤细胞迁移和增殖.
- 自然药物在血管正常化和增强化疗疗疗效方面表现出潜力.
结论:
- 调节瘤血管和机械微环境是关键的治疗目标.
- 血管正常化策略有望抑制瘤进展.
- 自然药物提供了一种潜在的途径,通过向瘤血管来改善癌症治疗结果.
更多相关视频
07:26Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
Published on: September 15, 2023
1.8K
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
8.9K
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
